Skip to main content

Table 1 Clinicopathologic features of our cohort of 60 endometrial cancer patients

From: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer

Endometrial cancer (grade) G1 G2 G3
No of cases 12 30 18
Age: years
Median (range)
57
(48–71)
57
(30–73)
61
(52–78)
BMI > 30% 41.7 45.4 28.7
Type I (%)
Type II (%)
100.0
0.0
96.7
3.3
66.7
33.3
FIGO stage (2009) (%)
 IA 100.0 73.1 13.3
 IB 0.0 19.2 26.7
 II 0.0 7.7 20.0
 IIIA 0.0 0.0 6.7
 IIIB 0.0 0.0 13.3
 IIIC1 0.0 0.0 20.0
 IIIC2 0.0 0.0 0.0
 IVA 0.0 0.0 0.0
 IVB 0.0 0.0 0.0
MI > 50% (%) 0 31.1 88.3
LVSI (%) 0.0 6.6 77.7
Lymph node metastases (%) 0.0 0 17.5
Hypertension (%) 50.0 33.3 58.8
BMI ≥ 30 (%) 16.6 40 27.7